INTERVIEW: Turkish R&D Industry Sees Challenges Weighing On Growth
This article was originally published in PharmAsia News
Executive Summary
In an exclusive interview with PharmAsia News, Dr. Umit Dereli, acting secretary-general of the Research Based Pharmaceutical Companies (AIFD) association in Turkey, assesses the market’s performance in the first quarter, pointing to a generally strong performance. But this is underpinned by ongoing basic pricing and other problems that continue to weigh heavily on the industry.